- Radioligands and Targeted Pathways in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Clinical Scenarios: Metastatic CRPC
- Insights from ASCO GU 2025: Non-Muscle Invasive Bladder Cancer
- Developments in Muscle Invasive Bladder Cancer (MIBC)
- Navigating Combination Regimens for Advanced Clear-Cell RCC
- Emerging Treatments in Non-Clear Cell RCC
OncLive® State of the Science Summit™: Genitourinary Cancers
Tuesday, May 13, 2025
6:00 PM - 9:00 PM CDT
Complimentary Parking
In-Person Only
Event Chair
Hans Hammers, MD, PhD
UT Southwestern Harold C. Simmons Comprehensive Cancer Center
IN PARTNERSHIP WITH
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Location
OncLive - an MJH Life Sciences brand
Copyright 2024 (C) Intellisphere, LLC
2 Commerce Drive
Cranbury, NJ 08512